116 related articles for article (PubMed ID: 20589437)
1. Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration.
Molyneux G; Andrews M; Sones W; York M; Barnett A; Quirk E; Yeung W; Turton J
Cell Biol Toxicol; 2011 Feb; 27(1):13-40. PubMed ID: 20589437
[TBL] [Abstract][Full Text] [Related]
2. The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse.
Molyneux G; Gibson FM; Gordon-Smith EC; Pilling AM; Liu KC; Rizzo S; Sulsh S; Turton JA
Int J Exp Pathol; 2005 Dec; 86(6):415-30. PubMed ID: 16309546
[TBL] [Abstract][Full Text] [Related]
3. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
[TBL] [Abstract][Full Text] [Related]
4. Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.
Turton JA; Sones WR; Andrews CM; Pilling AM; Williams TC; Molyneux G; Rizzo S; Gordon-Smith EC; Gibson FM
Int J Exp Pathol; 2006 Feb; 87(1):49-63. PubMed ID: 16436113
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF.
Iwasaki M; Adachi Y; Minamino K; Suzuki Y; Zhang Y; Okigaki M; Nakano K; Koike Y; Wang J; Mukaide H; Taketani S; Mori Y; Takahashi H; Iwasaka T; Ikehara S
J Am Soc Nephrol; 2005 Mar; 16(3):658-66. PubMed ID: 15689404
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
8. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
Kovacs CJ; Johnke RM; Evans MJ; Emma DA; Hooker JL
Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.
Emmenegger U; Man S; Shaked Y; Francia G; Wong JW; Hicklin DJ; Kerbel RS
Cancer Res; 2004 Jun; 64(11):3994-4000. PubMed ID: 15173013
[TBL] [Abstract][Full Text] [Related]
10. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.
Mizushima Y; Morikage T; Kuwahara T; Yano S
J Biol Response Mod; 1990 Dec; 9(6):576-83. PubMed ID: 1705961
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
12. Mice primed with swainsonine are protected against doxorubicin-induced lethality.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1089-99. PubMed ID: 14682391
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
14. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
15. The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.
Sadeghi B; Jansson M; Hassan Z; Mints M; Hägglund H; Abedi-Valugerdi M; Hassan M
Bone Marrow Transplant; 2008 May; 41(10):895-904. PubMed ID: 18223695
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
17. The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.
Saint-Dizier D; Sancier M; Cudennec CA
Anticancer Res; 1990; 10(3):765-71. PubMed ID: 2369090
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1037-48. PubMed ID: 14682385
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of N-Methylolacrylamide (CAS No. 924-42-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 352():1-204. PubMed ID: 12704432
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
